Phosphatidylinositol 3-Kinase
Showing 1 - 25 of >10,000
Metastatic Breast Cancer Trial in East Melbourne (BYl719)
Completed
- Metastatic Breast Cancer
-
East Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Aug 11, 2022
A NIS of Alpelisib in Combination With Fulvestrant in
Not yet recruiting
- Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation
- Alpelisib
- Fulvestrant
- (no location specified)
Aug 9, 2022
Follicular Lymphoma Trial in Germany (Copanlisib, Obinutuzumab)
Recruiting
- Follicular Lymphoma
-
München, Bavaria, Germany
- +39 more
May 19, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,
Recruiting
- Chronic Lymphocytic Leukemia
- +9 more
- BGB-10188
- +2 more
-
Adelaide, Australia
- +12 more
Jan 6, 2023
Safety Issues, Efficacy, Self Trial in Beijing (TQB3525)
Active, not recruiting
- Safety Issues
- Efficacy, Self
-
Beijing, ChinaPeking University Shougang Hospital
Dec 29, 2020
Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)
Recruiting
- Activated PI3K-delta Syndrome
- Immunodeficiency Primary
-
Shanghai, Shanghai, China
- +1 more
Mar 21, 2022
Marginal Zone Lymphoma, Follicular Lymphoma Trial in China (HMPL-689)
Recruiting
- Marginal Zone Lymphoma
- Follicular Lymphoma
-
Hefei, Anhui, China
- +35 more
Jun 7, 2021
Xospata in Relapsed or Refractory Acute Myeloid Leukemia With
Recruiting
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
- Gilteritinib Exposure
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +4 more
Aug 18, 2022
Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)
Recruiting
- Non Small Cell Lung Cancer
- Metformin Hydrochloride
- Placebo
-
Mexico City, MexicoInstituto Nacional de Cancerologia
Jul 21, 2022
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)
Recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Iadademstat
- Gilteritinib Oral Tablet
-
Boston, Massachusetts
- +2 more
Jan 18, 2023
Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,
Not yet recruiting
- Solid Tumors, Adult
- +7 more
- Alpelisib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 21, 2022
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem
Recruiting
- Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
- gilteritinib
- +3 more
-
Cincinnati, Ohio
- +18 more
Jan 20, 2023
Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Barcelona, Madrid (Mitapivat, Mitapivat-matching )
Recruiting
- Pediatric Pyruvate Kinase Deficiency
- Pediatric Hemolytic Anemia
- Mitapivat
- Mitapivat-matching placebo
-
Barcelona, Spain
- +1 more
Aug 8, 2022
Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax
Recruiting
- Chronic Lymphocytic Leukemia
-
London, London, City Of, United Kingdom
- +9 more
Jan 13, 2023
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)
Not yet recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- XY0206
- Salvage Chemotherapy
- (no location specified)
May 24, 2023
Tissue Samples From Breast Cancer Who Were Treated on Clinical
Completed
- Breast Cancer
- diagnostic laboratory biomarker analysis
- (no location specified)
Jul 1, 2019
Mild Cognitive Impairment Trial (Lithium Carbonate)
Completed
- Mild Cognitive Impairment
- Lithium Carbonate
- (no location specified)
Aug 5, 2021
Lymphoma, Non-Hodgkin Lymphoma Trial in Munich (PQR309)
Completed
- Lymphoma
- Non-Hodgkin Lymphoma
-
Munich, Bavaria, GermanyMedizinische Klinik und Poliklinik III
Jun 27, 2019
Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Spain, United States (Mitapivat, Mitapivat-matching )
Recruiting
- Pediatric Pyruvate Kinase Deficiency
- Pediatric Hemolytic Anemia
- Mitapivat
- Mitapivat-matching placebo
-
Phoenix, Arizona
- +3 more
Aug 8, 2022